| Title | Cancer Immunology, Immunotherapy |
| Abbreviation | Cancer Immunol. Immunother. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1) |
| h-index | 136 |
| Overall Rank/Ranking | 1871 |
| SCImago Journal Rank (SJR) | 1.663 |
| Impact Score | 5.25 |
| Publisher | Springer Science and Business Media Deutschland GmbH |
| Country | Germany |
| ISSN | 14320851, 03407004 |
| Best Quartile | Q1 |
| Coverage History | 1976-2023 |
Cancer Immunology, Immunotherapy is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1). It is published by Springer Science and Business Media Deutschland GmbH. The overall rank of Cancer Immunology, Immunotherapy is 1871. According to SCImago Journal Rank (SJR), this journal is ranked 1.663. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 136. The best quartile for this journal is Q1.
The ISSN of Cancer Immunology, Immunotherapy journal is 14320851, 03407004. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Immunology, Immunotherapy is cited by a total of 3967 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Cancer Immunology, Immunotherapy is 5.25, which is computed in 2024 as per its definition. Cancer Immunology, Immunotherapy IF is decreased by a factor of 0.55 and approximate percentage change is -9.48% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Cancer Immunology, Immunotherapy is 5.25. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5.25 |
| 2022 | 5.80 |
| 2021 | 6.95 |
| 2020 | 6.19 |
| 2019 | 5.25 |
| 2018 | 5.02 |
| 2017 | 4.38 |
| 2016 | 5.01 |
| 2015 | 5.36 |
| 2014 | 4.40 |
Cancer Immunology, Immunotherapy has an h-index of 136. It means 136 articles of this journal have more than 136 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Immunology, Immunotherapy is 14320851, 03407004. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Immunology, Immunotherapy is 1871. According to SCImago Journal Rank (SJR), this journal is ranked 1.663. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.663 |
| 2022 | 1.663 |
| 2021 | 1.723 |
| 2020 | 2.389 |
| 2019 | 1.957 |
| 2018 | 2.085 |
| 2017 | 1.899 |
| 2016 | 2.113 |
| 2015 | 2.086 |
| 2014 | 1.823 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1871 |
| 2022 | 1786 |
| 2021 | 1638 |
| 2020 | 985 |
| 2019 | 1368 |
| 2018 | 1281 |
| 2017 | 1509 |
| 2016 | 1246 |
| 2015 | 1330 |
| 2014 | 1656 |
Cancer Immunology, Immunotherapy is published by Springer Science and Business Media Deutschland GmbH. It's publishing house is located in Germany. Coverage history of this journal is as following: 1976-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Immunology, Immunotherapy is Cancer Immunol. Immunother.. This abbreviation ('Cancer Immunol. Immunother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Immunology, Immunotherapy latest impact IF is 5.25. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.95 (2021) and 4.38 (2017), respectively, in the last 10 years. Moreover, its average IS is 5.36 in the previous 10 years.
The Cancer Immunology, Immunotherapy has an SJR (SCImago Journal Rank) of 1.663, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.389 in 2020 and the lowest being 1.663 in 2023. Furthermore, the average SJR of the Cancer Immunology, Immunotherapy over the previous 10-year period stands at 5.36.
The latest h-index of the Cancer Immunology, Immunotherapy is 136.
The Cancer Immunology, Immunotherapy is published by the Springer Science and Business Media Deutschland GmbH, with its country of publication being the Germany.
The Cancer Immunology, Immunotherapy is currently ranked 1871 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 985 in 2020 and its lowest position of 1871 in 2023.
The standard ISO4 abbreviation for the Cancer Immunology, Immunotherapy is Cancer Immunol. Immunother..
Cancer Immunology, Immunotherapy is classified as a journal that the Springer Science and Business Media Deutschland GmbH publishes.
The Cancer Immunology, Immunotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Immunology, Immunotherapy is assigned the following International Standard Serial Numbers (ISSN): 14320851, 03407004.
The best quartile for the Cancer Immunology, Immunotherapy is Q1 (2023).
The Cancer Immunology, Immunotherapy coverage history can be summarized as follows: 1976-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
| Mathematical Modelling and Analysis | journal | 11193 | Vilnius Gediminas Technical University | 29 | 1.75 |
| Abacus | journal | 5997 | Wiley-Blackwell Publishing Ltd | 53 | 2.75 |
| Transnational Corporations | journal | 11181 | UNCTAD United Nations Conference on Trade and Development | 28 | 1.83 |
| Population Review | journal | 22638 | Sociological Demography Press | 14 | 0.54 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 5.25 |
| 2022 | 5.80 |
| 2021 | 6.95 |
| 2020 | 6.19 |
| 2019 | 5.25 |
| 2018 | 5.02 |
| 2017 | 4.38 |
| 2016 | 5.01 |
| 2015 | 5.36 |
| 2014 | 4.40 |
